Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05791084
Other study ID # 2021-04031
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date March 30, 2029

Study information

Verified date March 2023
Source Jonkoping University
Contact maria Brovall, ass prof
Phone +46705501097
Email maria.brovall@ju.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To examine the effect of a preparatory digital tool including a new instruction for deep inspiration breath hold (DIBH), before start of radiation therapy in women diagnosed with left sided breast cancer, compared with usual care.


Description:

The following questions will be posted: - Are there any differences in levels of distress (primary outcome) between the control and intervention group at baseline and over time? - Are there any differences in preparedness for RT (secondary outcomes) between the control and intervention group at baseline and over time? - Are there any correlations between Health Literacy (HL) levels (secondary outcome) and levels of distress (primary outcome) in the control and intervention group? - Are there any differences in objective clinical variables (chest mobility and respiratory movements and planned absorbed dose to the heart) between the control and intervention group before and after the intervention (baseline and at planning CT)? - Which patterns of practice and use of the application (when, how, how often and for how long) can be discerned from the intervention group? - Are there any correlations between different levels of practice and use of the digital tool and primary and secondary outcomes? - How do patients in the different groups (control and intervention group) describe their experience of care and information process during RT with DIBH? - Are there differences regarding health economic variables in terms of costs and health care usage (e.g., estimated time for planning and conducting computed tomography (CT), number of scheduled CT examinations) and patient effects (e.g. co-morbidities (heart related), sick leave, and quality-adjusted life year (QALYs) between patients in control- or interventions group? - Are there any differences regarding effects on environmental aspects and costs in the different groups (control and intervention)?


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 160
Est. completion date March 30, 2029
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: Inclusion criteria for the study: - patients > 18 years of age - with a left-sided breast cancer diagnosis or DCIS - who are to receive RT with DIBH technology - with curative intention - preparatory CT visit minimum 7 days to a maximum of 4 weeks - able to speak and understand good enough Swedish to be able to assimilate content in the mobile app and answer surveys and interview questions - have access to a smart mobile phone. Exclusion Criteria: - patients receiving palliative RT or neoadjuvant chemotherap - Planning CT starting < 7 days - people with some form of orthopedic, rheumatological or neurological injury or disease that limits the possibility of carrying out the intervention.

Study Design


Intervention

Other:
mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts.
The DIBH-App consists of 1) a mobile application that patients download to their own smart mobile phone, and 2) associated stretch-sensors that are attached around the chest and connected to the mobile phone via Bluetooth. Visually, the graphics is similar to the software used for DIBH in the RT department. Coaching takes place through instructional videos, text, and audio recordings (Image 2). The following information will be recorded and stored: date and time of practice, outcome of each session (including sensor data and calibration parameters), and user behavior within the application (such as screen visits, FAQ sections viewed, and key button presses).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Jonkoping University

Outcome

Type Measure Description Time frame Safety issue
Other Logged data from the CT machine will be collected at all treatment occasions on all included patients. Estimation of time for planning CT (min) at Ct planning visit, one week
Other Logged data from the CT machine number of correct and failed breathing attempts that the patient needs for approved CT. (nr of CT) at Ct planning visit, one week
Other Data from the journal Data from the journal on all included patients, looking at extra visits for making planning CT. at Ct planning visit, one week
Other Logged data from the RT machine Logged data from radiation treatment devices (linear accelerators) will be collected at all treatment occasions on all included patients. Estimation of time on RT at Ct planning visit, one week
Other Logged data from the CT machine will be collected at all treatment occasions on all included patients. Estimation of time on planning CT (min) 3 weeks post RT
Other Logged data from the CT machine number of CT images, 3 weeks post RT
Other Logged data from the journal Logged data from the journal will be collected on all treatment occasions on all included patients. and extra visits during the treatment period and after. 3 weeks post RT
Other Logged data from RT machine Logged data from the radiation treatment devices (linear accelerators) will be collected at all treatment occasions on all included patients. Estimation of time on RT on each occasion. 3 weeks post RT
Other Measurement of chest mobility Respiratory Objective Measurements. Thorax extension: chest mobility will be measured with a measuring tape, during maximum breathing movements, with the addition of voluntary movements of the chest (the measurement is in centimeters and millimeters) at baseline when inclusion/randomisation
Other Measurement of chest mobility Respiratory Objective Measurements. Thorax extension: chest mobility will be measured with a measuring tape, during maximum breathing movements, with the addition of voluntary movements of the chest(the measurement is in centimeters and millimeters) at planning CT, one week
Other RMMI test Respiratory movements will be measured on ten patients in the pilot-test, from group B with the Respiratory Movement Measuring Instrument (RMMI) (ReMo Inc. Keldnaholt, Reykjavik, Iceland). The measurement will be performed during maximum breathing movements and is measured bilaterally in the upper and lower part of the thorax and the abdomen. The measurement will be performed by a physiotherapist in the project. The test will evaluate if the measurement with logged data in the app and the respiratory objective measurements are reliable measurements. If not, this measurement will be done to patients in the group B in the RCT study to evaluate the effect. at planning CT visit, one week
Other Planned and given absorbed RT dose to the heart during RT Given and planned RT-heart dose will be obtained from the journal. Note possibly heart or lung diseases baseline at inclusion /randomisation
Other Planned and given absorbed RT dose to the heart during RT Given and planned RT-heart dose will be obtained from the journal, 5 years after RT. Note possibly heart or lung diseases 5 years post RT
Other Demographic information. Modified version of The self-administrated comorbidity, The Self-Administered Comorbidity Modified version of The Self-Administered Comorbidity. Journal data will be collected. Data will be collected regarding type and dose of chemotherapy for control of e.g., heart toxicity, other diseases, medications, sick-leave. baseline at inclusion/randomisation
Other Demographic information, Modified version of The self-administrated comorbidities, The Self-Administered Comorbidity Modified version of The Self-Administered Comorbidity. Journal data will be collected. Data will be collected regarding type and dose of chemotherapy for control of e.g., heart toxicity, other diseases, medications, sick-leave. 5 years follow up post RT
Other Training patterns Number of times practiced and maximal movement at each training session (min vs max). Logged data from app. from baseline at inclusion/randomisation
Other Training patterns Number of times practiced and maximal movement at each training session (min vs max). Logged data from app. up until the CT planning vistit, one week
Other Environmental effects Modes of travelling, distance to clinic (km) and time spent for RT treatment (min). Questions answered i kilometer per mile, time estimation,type of transportation (car, buss, etc). 3 weeks post RT
Other Focus group interview The focus group interviews are based on open-ended questions, and they will be asked to describe their experience of the care process in breath-adapted radiation therapy (before, during and after the treatment) and the breathing practice based on their group affiliation. Participants are selected within each group with a view to a spread of age, socio-demographic characteristics, and treatment approach. 3 weeks post RT
Primary Distress (DIS-A) The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress. Time 1, baseline at randomisation/inclusion
Primary Distress (DIS-A) The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress. time 2, at CT-planning visit one week
Primary Distress (DIS-A) The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress. time 3, 3 weeks post RT
Primary Distress (DIS-A) The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress. time 4, 6 month post RT
Primary Distress (DIS-A) The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress. time 5, 5 years after RT
Secondary HRQoL and Health economic (EQ-5D-5L) Health economic measured with EQ-5D-5L a health-related quality of life instrument used to calculate quality-adjusted life years (QALY) . Its design accounts for the need for a direct link between the measurement and valuation of health, whereby every health state that patients might report on the EQ-5D-5L instrument can be summarised by a single value. In order to be used in the calculation of quality-adjusted life years (QALYs; a metric used in cost-utility anal-ysis that combines survival and HRQL), these values need to summarise how good or bad each health state is on a scale anchored at 1 (full health) and 0 (a state equivalent to dead). Values less than 0 represent health states considered to be or modelled as worse than dead. at baseline when inclusion/randomisation
Secondary HRQoL and Health economic (EQ-5D-5L) Health economic measured with EQ-5D-5L a health-related quality of life instrument used to calculate quality-adjusted life years (QALY) . Its design accounts for the need for a direct link between the measurement and valuation of health, whereby every health state that patients might report on the EQ-5D-5L instrument can be summarised by a single value. In order to be used in the calculation of quality-adjusted life years (QALYs; a metric used in cost-utility anal-ysis that combines survival and HRQL), these values need to summarise how good or bad each health state is on a scale anchored at 1 (full health) and 0 (a state equivalent to dead). Values less than 0 represent health states considered to be or modelled as worse than dead. 5 years post RT
Secondary e-HL (eHLQ) eHealth Literacy Questionnaire-Swedish version, aims to measure a broad range of literacy skills, which could make it useful in assessing the effects of strategies for delivering online information and applications. eHEALS is an 8-item instrument with each item scored on a 5-point Likert scale.Each item is rated on a 5-point. Likert scale, ranging from 1 = strongly disagree to 5 = strongly agree. at baseline when inclusion/randomisation
Secondary Communicative, critical and functional HL consists of 14 statements with 4 points Likert scales (1-4). The statements ask how often (never to often) patients have trouble with reading or understanding leaflets from healthcare providers/hospital or pharmacy (functional health literacy; 5 items), have difficulty (easy to rather difficult) performing certain actions in relation to health information (communicative (5 items) and critical (4 items) health literacy). at baseline when inclusion/randomisation
Secondary Preparedness(PCSQ-24) Modified version of the Preparedness for Colorectal Cancer Surgery Questionnaire, with 28 items measuring preparedness for surgery was developed covering four domains.All items were rated on a Likert-type scale with the following translated response options: Strongly agree, Agree somewhat, Disagree somewhat, and Totally disagree (with corresponding values ranging from 4 to 1) at CT planning visit, one week
Secondary The Radiotherapy Experience Questionnaire, Swedish modified version The Radiotherapy Experience Questionnaire (RTEQ) with 23 items. This instrument assesses the patient's experiences of the external RT procedure and includes psychological stress, physical discomfort and coping during the external RT procedure.t Likert-type scale for response options, which ranged from 1 = I strongly agree to 6 = I strongly disagree 3 weeks post RT
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05782868 - Expressive Writing Intervention Study N/A
Not yet recruiting NCT06006936 - Testing an Evidence-Based Self-Help Program for Infertility-Related Distress in Women N/A
Not yet recruiting NCT06430203 - Indigenous Youth and Young Adults With Diabetes Peer Mentorship Program N/A
Not yet recruiting NCT05510453 - Low-intensity Online Intervention for Young People N/A
Completed NCT04890600 - COVID-19 and Psycological Well-being in Healthcare Workers
Recruiting NCT06114875 - Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1) N/A
Recruiting NCT06114849 - Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3) N/A
Recruiting NCT05783401 - Digital Voice Analysis as a Measure of Frailty and Distress
Active, not recruiting NCT05590741 - An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy N/A
Completed NCT05161312 - A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial N/A
Recruiting NCT06091189 - Internalized Stress in Relation to Alcohol Consumption Early Phase 1
Not yet recruiting NCT05555381 - Anxiety, Stress and Sleep Problems in People With Early Onset Dementia N/A
Completed NCT05291533 - Patient Experiences With Virtual Reality Mindfulness Skills Training N/A
Completed NCT05001542 - Digital Interventions for Detection and Reduction of Moral Distress N/A
Recruiting NCT06111820 - Evaluation of Training Curriculum and Service of Improving Access to Community Therapies N/A
Not yet recruiting NCT06405373 - Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes N/A
Not yet recruiting NCT06405386 - Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes N/A
Enrolling by invitation NCT05955898 - The Development and Evaluation of a Single Session Intervention for Parent Distress Tolerance N/A
Recruiting NCT05779761 - Brief Interventions for Coping With Distress N/A
Not yet recruiting NCT06099743 - ASCENT Intervention for Brain Tumor Patients N/A